UPSTARNEWS
← 뉴스 목록
enUS

Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer

GlobeNewswire (all releases)· www.globenewswire.com
10/25/2026, 11:00 AM
1분 소요